Another look at the financial data of Pharmaceutical companies. Who has the big bucks to spend on research? A picture is worth a thousand words.
Similar Posts
Novel Catalyst
There are many reactions in biology that are catalyzed by enzymes but there are other reactions in industrial chemistry that use industrial catalysts which have primarily been platinum based. A paper in Nature https://www.nature.com/articles/s41467-026-68432-1 promises a unique shaped catalyst that can split H-H bond and other reactions. It is a unique structure and promises to…
Schizophrenia drugs
Schizophrenia is mental disorder characterized by problems in thinking, perception, emotions and behavior. It requires long term medication to manage symptoms. There are many drugs in the market to treat schizophrenia: Antipsychotics: These block the dopamine D2 receptor, though with side effects such as tremors and tardive dyskinesia. The Atypical antipsychotics affect both the dopamine…
PROTAC databases
PROTAC (Proteolysis targeting chimera) is fantastic technology that can degrade specific proteins. It uses a small molecule with a capability to bind the protein to be degraded and an active site that binds to E3 ubiquitin ligase. Using the PROTAC pulls the protein into ubiquitin based degradation pathways by ubiquitination of the protein and subsequent…
Mechanism of action of drugs
As more drugs are discovered, it is often assumed that we understand the logical mechanisms of how drug acts on specific physiology and in terms of bacteria and virus, how that drug inhibits the growth or survival of the microbe. However, in many cases the mechanism of action is understood much later. In the early…
